H&R GmbH & Co. KGaA (ETR:2HRA)

Market Cap	163.03M +23.0%
Revenue (ttm)	1.30B -3.1%
Net Income	3.94M -28.8%
EPS	0.11 -22.0%
Shares Out	37.22M
PE Ratio	38.19
Forward PE	35.52
Dividend	0.10 (2.28%)
Ex-Dividend Date	May 28, 2025

Volume	2,600
Average Volume	2,501
Open	4.430
Previous Close	4.380
Day's Range	4.430 - 4.430
52-Week Range	3.410 - 5.040
Beta	0.37
RSI	41.97
Earnings Date	Mar 31, 2026

About H&R GmbH & Co. KGaA

H&R GmbH & Co. KGaA engages in the manufacture and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts in Europe, Africa, Asia, and internationally. It operates in three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment manufactures and distributes paraffins, white oils, plasticizers, base oils, lubricants, and other crude oil-based specialty products, as well as by-products, such as feedstocks and bunker fuels. The ChemPharm Sales segment processes and distributes...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1919
• Employees: 1,719
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: 2HRA

Financial Performance

In 2024, H&R GmbH & Co. KGaA's revenue was 1.35 billion, a decrease of -1.06% compared to the previous year's 1.36 billion. Earnings were 10.62 million, an increase of 0.63%.